At ARUP Laboratories, we understand that the clinical needs of children are unique, often urgent, and deeply personal. Not one among us can bear to see a child suffer.

Through the years, ARUP has remained committed to combining a robust menu of pediatric tests with an investment in research, education, and consultation that helps pediatric care teams make the most informed decisions for each child.

We’re proud to lead the clinical laboratory industry in the validation of pediatric-specific reference intervals for test results interpretation and in advancing diagnostic innovation in specialty areas such as biochemical genetics, cytogenetics, autoimmune disease testing, rapid whole genome sequencing, newborn drug screening, pediatric oncology testing, and more.

In this edition of Magnify, we share our approach to pediatric testing, with a special focus on:

• The promise of rapid whole genome sequencing for critically ill newborns, including what we’ve learned from collaborative efforts that deliver answers in days and inform timely care
• The work of our Hematopathology and Cytogenetics teams for the Children’s Oncology Group to detect genetic drivers in pediatric leukemia and clarify findings that guide targeted therapy
• Laboratory stewardship in children’s hospitals and how the right guardrails help ensure the right test at the right time, guided by evidence and empathy for young patients and their families

Spend some time with this edition, and I believe you’ll emerge with a clear sense of why our teams—and the hospital partners we serve—are unwavering in our efforts on behalf of children. It’s work worth celebrating.